• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

TetraLogic Pharmaceuticals Corp

+ Add to Watchlist

TLOG:US

4.1800 USD 0.0200 0.48%

As of 20:10:00 ET on 10/01/2014.

Snapshot for TetraLogic Pharmaceuticals Corp (TLOG)

Open: 4.2600 Day's Range: 3.9801 - 4.2600 Volume: 29,546
Previous Close: 4.1600 52wk Range: 3.5500 - 14.7500 1-Yr Rtn: -

Stock Chart for TLOG

No chart data available.
  • TLOG:US 4.1800
  • 1D
  • 1M
  • 1Y
4.1600
Interactive TLOG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TLOG

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -7.4300
Est. PEG Ratio -
Market Cap (M USD) 93.24
Shares Outstanding (M) 22.31
30 Day Average Volume 50,521
Price/Book (mrq) 1.7631
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TLOG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TLOG

TetraLogic Pharmaceuticals Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers. TetraLogic Pharmaceuticals Corporation offers its products throughout the United States.

J Kevin Buchi "Kevin"President/CEOPete A MeyersCFO/Treasurer
Lesley Russell CooperCOO/Chief Medical OfficerC Glenn BegleySenior VP:Research & Dev
More Company Profile & Key Executives for TLOG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil